Enlivex Average Assets vs Interest Expense Analysis

ENLV Stock  USD 3.86  0.05  1.28%   
Trend analysis of Enlivex Therapeutics balance sheet accounts such as Total Current Liabilities of 3.6 M or Total Stockholder Equity of 53.7 M provides information on Enlivex Therapeutics' total assets, liabilities, and equity, which is the actual value of Enlivex Therapeutics to its prevalent stockholders. By breaking down trends over time using Enlivex Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.

About Enlivex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Enlivex Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Enlivex Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Enlivex Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Enlivex currently owns. An asset can also be divided into two categories, current and non-current.

Enlivex Therapeutics Balance Sheet Chart

Enlivex Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Enlivex Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Enlivex Therapeutics' Common Stock Total Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to climb to about 22.2 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 2.3 M in 2024.

Total Assets

Total assets refers to the total amount of Enlivex Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Enlivex Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Enlivex Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Enlivex Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Enlivex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enlivex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.Selling General Administrative is likely to climb to about 8.1 M in 2024, despite the fact that Tax Provision is likely to grow to (3.4 K).

Enlivex Therapeutics fundamental ratios Correlations

0.580.790.970.750.410.550.61-0.130.820.570.510.460.190.510.52-0.510.84-0.34-0.360.60.30.480.510.470.59
0.580.930.540.320.420.490.38-0.30.840.110.720.470.260.050.09-0.050.55-0.42-0.550.560.750.760.690.540.55
0.790.930.760.630.550.690.35-0.330.920.340.680.60.330.270.32-0.260.74-0.51-0.550.570.570.690.670.570.58
0.970.540.760.750.50.580.57-0.150.790.580.550.550.260.480.6-0.480.89-0.4-0.390.640.270.520.560.530.63
0.750.320.630.750.440.620.04-0.150.520.670.160.440.220.590.64-0.590.6-0.34-0.150.17-0.070.110.170.230.26
0.410.420.550.50.440.85-0.14-0.440.66-0.040.780.980.78-0.230.080.230.76-0.96-0.790.650.070.720.80.840.66
0.550.490.690.580.620.85-0.21-0.530.680.350.570.890.590.20.37-0.20.78-0.79-0.60.39-0.060.520.590.570.36
0.610.380.350.570.04-0.14-0.210.210.480.10.38-0.1-0.160.140.07-0.140.390.14-0.140.610.60.390.360.280.56
-0.13-0.3-0.33-0.15-0.15-0.44-0.530.21-0.33-0.09-0.24-0.41-0.3-0.01-0.130.01-0.360.420.5-0.15-0.16-0.2-0.25-0.36-0.12
0.820.840.920.790.520.660.680.48-0.330.140.830.690.410.050.13-0.050.85-0.66-0.710.810.580.810.830.770.79
0.570.110.340.580.67-0.040.350.1-0.090.14-0.220.06-0.10.970.95-0.970.370.230.31-0.23-0.25-0.23-0.22-0.29-0.27
0.510.720.680.550.160.780.570.38-0.240.83-0.220.80.61-0.36-0.120.360.74-0.79-0.840.920.550.991.00.920.88
0.460.470.60.550.440.980.89-0.1-0.410.690.060.80.77-0.140.170.140.81-0.92-0.770.650.080.740.820.820.62
0.190.260.330.260.220.780.59-0.16-0.30.41-0.10.610.77-0.31-0.050.310.49-0.69-0.560.490.050.570.630.660.49
0.510.050.270.480.59-0.230.20.14-0.010.050.97-0.36-0.14-0.310.88-1.00.220.380.43-0.34-0.25-0.36-0.37-0.44-0.38
0.520.090.320.60.640.080.370.07-0.130.130.95-0.120.17-0.050.88-0.880.430.130.23-0.15-0.22-0.13-0.11-0.18-0.18
-0.51-0.05-0.26-0.48-0.590.23-0.2-0.140.01-0.05-0.970.360.140.31-1.0-0.88-0.22-0.38-0.430.340.250.360.360.440.38
0.840.550.740.890.60.760.780.39-0.360.850.370.740.810.490.220.43-0.22-0.68-0.630.750.250.680.750.730.7
-0.34-0.42-0.51-0.4-0.34-0.96-0.790.140.42-0.660.23-0.79-0.92-0.690.380.13-0.38-0.680.84-0.68-0.12-0.73-0.81-0.87-0.7
-0.36-0.55-0.55-0.39-0.15-0.79-0.6-0.140.5-0.710.31-0.84-0.77-0.560.430.23-0.43-0.630.84-0.78-0.38-0.8-0.85-0.94-0.76
0.60.560.570.640.170.650.390.61-0.150.81-0.230.920.650.49-0.34-0.150.340.75-0.68-0.780.570.890.920.910.98
0.30.750.570.27-0.070.07-0.060.6-0.160.58-0.250.550.080.05-0.25-0.220.250.25-0.12-0.380.570.60.520.440.58
0.480.760.690.520.110.720.520.39-0.20.81-0.230.990.740.57-0.36-0.130.360.68-0.73-0.80.890.60.980.880.85
0.510.690.670.560.170.80.590.36-0.250.83-0.221.00.820.63-0.37-0.110.360.75-0.81-0.850.920.520.980.930.89
0.470.540.570.530.230.840.570.28-0.360.77-0.290.920.820.66-0.44-0.180.440.73-0.87-0.940.910.440.880.930.91
0.590.550.580.630.260.660.360.56-0.120.79-0.270.880.620.49-0.38-0.180.380.7-0.7-0.760.980.580.850.890.91
Click cells to compare fundamentals

Enlivex Therapeutics Account Relationship Matchups

Enlivex Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets17.6M40.4M95.1M67.6M60.9M30.7M
Other Current Liab5.5M3.7M3.2M4.0M3.6M2.3M
Total Current Liabilities6.0M4.4M4.7M6.6M5.9M3.6M
Total Stockholder Equity11.3M35.5M85.0M56.8M51.2M53.7M
Accounts Payable316K463K878K1.9M1.8M1.2M
Cash3.9M5.7M11.2M47.8M55.0M57.7M
Other Assets72K81K0.0412K370.8K259.0K
Short Term Investments8.1M30.0M72.9M299K343.9K326.7K
Other Current Assets510K32.4M12.3M2.4M2.7M2.6M
Total Liab6.3M4.9M10.1M10.8M9.7M5.5M
Common Stock1.2M1.6M2.1M2.1M2.4M2.6M
Property Plant Equipment1.1M2.1M2.5M14.9M17.1M18.0M
Net Debt(3.8M)(5.5M)(10.6M)(43.0M)(38.7M)(36.7M)
Retained Earnings(25.7M)(37.5M)(52.0M)(83.0M)(74.7M)(71.0M)
Cash And Short Term Investments12.0M35.7M84.1M48.1M55.3M58.1M
Net Receivables2.4M1.2M2.2M647K744.1K879K
Common Stock Shares Outstanding8.6M13.2M17.9M18.4M21.2M22.2M
Liabilities And Stockholders Equity17.6M40.4M95.1M67.6M77.8M81.7M
Other Stockholder Equity37.1M70.4M133.8M136.6M157.1M165.0M
Total Current Assets16.4M38.1M86.4M52.3M60.2M63.2M
Property Plant And Equipment Net1.1M2.1M8.2M14.9M17.1M18.0M
Non Current Assets Total1.1M2.2M8.7M15.3M17.6M18.5M
Non Currrent Assets Other(329K)8K482K105K120.8K126.8K
Property Plant And Equipment Gross648K2.1M10.2M18.4M21.2M22.3M
Non Current Liabilities Total298K499K5.4M4.2M4.8M5.1M
Net Tangible Assets11.3M35.5M85.0M56.8M65.4M32.8M
Net Invested Capital11.3M35.5M85.0M56.8M65.4M36.8M
Net Working Capital10.4M33.7M81.7M45.7M52.6M33.7M
Capital Stock1.2M1.6M2.1M2.1M2.4M1.7M

Pair Trading with Enlivex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enlivex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Enlivex Stock

  0.69WU Western Union Financial Report 7th of May 2024 PairCorr

Moving against Enlivex Stock

  0.73SABR Sabre Corpo Financial Report 2nd of May 2024 PairCorr
  0.7UI Ubiquiti Networks Financial Report 3rd of May 2024 PairCorr
  0.65KN Knowles Cor Financial Report 25th of April 2024 PairCorr
  0.64ZD Ziff Davis Financial Report 14th of May 2024 PairCorr
  0.63U Unity Software Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Enlivex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enlivex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enlivex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enlivex Therapeutics to buy it.
The correlation of Enlivex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enlivex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enlivex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enlivex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Enlivex Stock analysis

When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Enlivex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enlivex Therapeutics. If investors know Enlivex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enlivex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.47)
Return On Assets
(0.28)
Return On Equity
(0.53)
The market value of Enlivex Therapeutics is measured differently than its book value, which is the value of Enlivex that is recorded on the company's balance sheet. Investors also form their own opinion of Enlivex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enlivex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enlivex Therapeutics' market value can be influenced by many factors that don't directly affect Enlivex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enlivex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enlivex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enlivex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.